AT
All Things Considered
Merck and Moderna release promising data on cancer vaccine trial
0:00-3:33
A study of a personalized vaccine combined with an existing immunotherapy found the treatment helped patients with melanoma avoid cancer recurrence. The combination trains the patient's immune system to go after cancer cells.
Publisher
All Things Considered
Published
October 23, 2026
Duration
4 min
Format
Podcast
Category
News · Daily News
Source
RSS feed
AT
All Things Considered
@allthingsconsidered
#merck #modernareleasepromising #cancervaccinetrial
